Concepedia

Adinarayana Nandikolla

AN

Statistics

Publications

9

Citations

199

H-Index

9

Active since

2019

Affiliations

Birla Institute of Technology and Science, Pilani(Current)

Birla Institute of Technology and Science - Hyderabad Campus

Medicina

University of Hyderabad

Universidad de León

Adinarayana Nandikolla is an author at Birla Institute of Technology and Science, Pilani specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2019–2022

9

Publications

9

Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents

Singireddi Srinivasarao, Adinarayana Nandikolla, Amaroju Suresh et al. · Bioorganic Chemistry · 2020 · 39 citations

, , +5

Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues

Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar et al. · RSC Advances · 2020 · 33 citations · Full text

Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis

Adinarayana Nandikolla, Singireddi Srinivasarao, Yogesh Mahadu Khetmalis et al. · Toxicology in Vitro · 2021 · 31 citations

, , +7

Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent quorum sensing in <i>Pseudomonas aeruginosa</i>

Singireddi Srinivasarao, Adinarayana Nandikolla, Shashidhar Nizalapur et al. · RSC Advances · 2019 · 23 citations · Full text

Seeking potent anti-tubercular agents: design and synthesis of substituted-<i>N</i>-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents

Singireddi Srinivasarao, Adinarayana Nandikolla, Amaroju Suresh et al. · RSC Advances · 2020 · 22 citations · Full text

1–5 of 9